Equity Capital Markets

Biomea Fusion

11/22
|
$100.0 Million
Biomea Fusion
Piper Sandler served as placement agent for Biomea Fusion on an ATM offering
Sub-Type
At the Market Offering
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$250.0 Million
d
Rithm Capital
Preferred Stock
Joint Bookrunner
s
Arrowhead Pharmaceuticals, Inc.
Follow-On Offering
Passive Bookrunner
b
Monte Rosa Therapeutics
Follow-On Offering
Active Bookrunner
r
Bright Minds Biosciences
Follow-On Offering
Active Bookrunner
e
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Left Bookrunner
e
Crinetics Pharmaceuticals
Follow-On Offering
Active Bookrunner
$7.3 Billion
s
Medline Industries
Initial Public Offering
Passive Bookrunner
w
Tenaya Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
s
Miami International Holdings, Inc.
Follow-On Offering
Active Bookrunner
$75.0 Million
w
Protara Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$172.5 Million
e
Capricor Therapeutics
Confidentially Marketed Follow-On Offering
Left Bookrunner
$158.7 Million
s
Kestra Medical Technologies
Follow-On Offering
Active Bookrunner
$300.0 Million
s
Compeer Financial
Perpetual Preferred Stock
Sole Initial Purchaser
$373.0 Million
z
Central Bancompany
Initial Public Offering
Joint Bookrunner
4
American Integrity Insurance Group
Follow-On Offering
Active Bookrunner
$40.2 Million
s
Fennec Pharmaceuticals
Confidentially Marketed Follow-On Offering
Lead Bookrunner

© 2026 Piper Sandler Companies. Since 1895. All rights reserved.